RNA Technologies in Cardiovascular Medicine and Research

MicroRNA.- An Overview of MicroRNA.- MicroRNAs and Their Potential.- miRNAs and Their Emerging Role in Cardiac Hypertrophy.- MicroRNAs and the Control of Heart Pathophysiology.- MicroRNA Systems Biology.- RNA Interference.- Targeting Viral Heart Disease by RNA Interference.- Design of siRNAs and shRNAs for RNA Interference: Possible Clinical Applications.- RNA Interference and MicroRNA Modulation for the Treatment of Cardiac Disorders.- Cardiac Delivery of Nucleic Acids by Transcriptional and Transductional Targeting of Adeno-Associated Viral Vectors.- Ribozymes.- Characterization of Hammerhead Ribozymes Potentially Suitable for the Treatment of Hyper-Proliferative Vascular Diseases.- Applications of Ribozymes and Pyrrole-Imidazole Polyamides for Cardiovascular and Renal Diseases.- Noncoding, Aptamer and Antisense RNAs.- Noncoding RNAs in Human Diseases.- Aptamers and siRNAs in Cardiovascular Disease.- Nucleic Acid Aptamers for Cardiovascular Therapeutics.- NF?B Decoy Oligodeoxynucleotide-Based Therapy in Cardiovascular Diseases.- Antisense Therapy for Restenosis Following Percutaneous Coronary Interventions.- Toxic RNA in Pathogenesis of Human Neuromuscular Disorders.